Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancerUENO, Hideki; OKUSAKA, Takuji; IKEDA, Masafumi et al.Oncology. 2004, Vol 67, Num 3-4, pp 215-221, issn 0030-2414, 7 p.Article

Chemotherapy for biliary tract cancer in JapanOKUSAKA, Takuji.Seminars in oncology. 2002, Vol 29, Num 6, pp 51-53, issn 0093-7754, 3 p., SUP20Conference Paper

Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapyUENO, Hideki; OKADA, Shuichi; OKUSAKA, Takuji et al.Oncology. 2000, Vol 59, Num 4, pp 296-301, issn 0030-2414Article

Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapySAISHO, Toshimitsu; OKUSAKA, Takuji; UENO, Hideki et al.Hepato-gastroenterology. 2005, Vol 52, Num 66, pp 1654-1658, issn 0172-6390, 5 p.Article

Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapyIKEDA, Masafumi; OKADA, Shuichi; TOKUUYE, Koichi et al.Cancer. 2001, Vol 91, Num 3, pp 490-495, issn 0008-543XArticle

Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma : outcomes and the associated elevation of alpha-fetoproteinTAKAYASU, Kenichi; MURAMATSU, Yukio; MIZUGUCHI, Yasunori et al.Journal of gastroenterology and hepatology. 2006, Vol 21, Num 1, pp 288-294, issn 0815-9319, 7 p., 2Article

A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinomaIKEDA, Masafumi; OKUSAKA, Takuji; UENO, Hideki et al.Cancer. 2005, Vol 103, Num 4, pp 756-762, issn 0008-543X, 7 p.Article

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinomaUENO, Hideki; OKADA, Shuichi; OKUSAKA, Takuji et al.Cancer chemotherapy and pharmacology. 2002, Vol 49, Num 2, pp 155-160, issn 0344-5704Article

Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injectionKUUIYAMA, Hitoshi; OKADA, Shuichi; OKUSAKA, Takuji et al.Journal of gastroenterology and hepatology. 2002, Vol 17, Num 11, pp 1205-1210, issn 0815-9319, 6 p.Article

Predictive factors for tumor response to chemotherapy in patients with pancreatic cancerFUJISHIRO, Mitsuhiro; OKADA, Shuichi; UENO, Hideki et al.Hepato-gastroenterology. 2000, Vol 47, Num 36, pp 1744-1746, issn 0172-6390Article

Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancerFURUSE, Junji; OKUSAKA, Takuji; BRIDGEWATER, John et al.Critical reviews in oncology/hematology. 2011, Vol 80, Num 1, pp 31-39, issn 1040-8428, 9 p.Article

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer : a multicenter phase II studyFURUSE, Junji; OKUSAKA, Takuji; BOKU, Narikazu et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 849-855, issn 0344-5704, 7 p.Article

CT evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver diseaseTAKAYASU, Kenichi; MURAMATSU, Yukio; MIZUGUCHI, Yasunori et al.American journal of roentgenology (1976). 2006, Vol 187, Num 2, pp 454-463, issn 0361-803X, 10 p.Article

Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injectionUENO, Hideki; OKADA, Shuichi; OKUSAKA, Takuji et al.Hepato-gastroenterology. 2001, Vol 48, Num 41, pp 1430-1434, issn 0172-6390Article

A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancerFURUSE, Junji; OKUSAKA, Takuji; OHKAWA, Shinichi et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 113-120, issn 0344-5704, 8 p.Article

Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment?HASHIMOTO, Kenji; UENO, Hideki; IKEDA, Masafumi et al.Oncology. 2009, Vol 77, Num 3-4, pp 217-223, issn 0030-2414, 7 p.Article

Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancerOKUSAKA, Takuji; ISHII, Hiroshi; FUNAKOSHI, Akihiro et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 5, pp 647-653, issn 0344-5704, 7 p.Article

A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancerUENO, Hideki; OKUSAKA, Takuji; IKEDA, Masafumi et al.Oncology. 2005, Vol 69, Num 5, pp 421-427, issn 0030-2414, 7 p.Article

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokineticsSUNAKAWA, Yu; FURUSE, Junji; OKUSAKA, Takuji et al.Investigational new drugs. 2014, Vol 32, Num 1, pp 104-112, issn 0167-6997, 9 p.Article

Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinomaFURUSE, Junji; OKUSAKA, Takuji; KANEKO, Shuichi et al.Cancer science. 2010, Vol 101, Num 12, pp 2606-2611, issn 1347-9032, 6 p.Article

New approaches for pancreatic cancer in JapanOKUSAKA, Takuji; MATSUMURA, Yasuhiro; AOKI, Kazunori et al.Cancer chemotherapy and pharmacology. 2004, Vol 54, pp S78-S82, issn 0344-5704, SUP1Conference Paper

Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findingsOKUSAKA, Takuji; OKADA, Shuichi; UENO, Hideki et al.Pancreas. 2001, Vol 22, Num 3, pp 279-284, issn 0885-3177Article

Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinomaOKUSAKA, Takuji; OKADA, Shuichi; TOKUUYE, Koichi et al.Cancer. 2001, Vol 91, Num 7, pp 1384-1389, issn 0008-543XArticle

A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosisIKEDA, Masafumi; OKUSAKA, Takuji; FURUSE, Junji et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 2, pp 463-470, issn 0344-5704, 8 p.Article

A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolizationTANAKA, Tsutomu; IKEDA, Masafumi; OKUSAKA, Takuji et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 4, pp 683-688, issn 0344-5704, 6 p.Article